Assessment and synthesis
Clinical effectiveness, diagnostic evidence, systematic reviews, transferability and structured appraisal of uncertainty.
Research area 02
How evidence, value and opportunity cost can support fairer decisions in resource-constrained health systems.
This programme brings together health economics, health technology assessment, economic evaluation and evidence appraisal. Its emphasis is practical: how decision-makers can compare technologies, programmes and policy options while making uncertainty, equity and implementation constraints visible.
Research map
The map keeps the programme broad enough to grow while making its boundaries and analytical emphasis visible.
Clinical effectiveness, diagnostic evidence, systematic reviews, transferability and structured appraisal of uncertainty.
Cost-effectiveness, budget impact, outcomes, opportunity cost, distributional effects and decision modelling.
HTA institutions, priority setting, stakeholder participation and the translation of evidence into health-system decisions.
Current questions
These are programme-level questions. Individual studies define narrower populations, interventions, systems, jurisdictions and periods.
Which evidence should inform adoption, reimbursement and disinvestment decisions in resource-constrained health systems?
How should economic evaluation represent uncertainty, equity, affordability and local implementation capacity?
What institutional arrangements allow HTA findings to influence policy transparently and consistently?
Research programme
Each stream can contain projects, publications, evidence reviews, methods, datasets and public outputs without duplicating their underlying records.
Reviews that connect intervention effects with costs, feasibility, equity and policy relevance.
Structured assessments of technologies and programmes, with explicit assumptions, uncertainty and local evidence needs.
Study materials, worked examples and visual explanations of economic evaluation and health-system decision methods.
Selected work
Records are drawn from reviewed programme assignments and retain their existing catalogue, publication and canonical identities.
Browse the catalogueNo current work meets both the programme’s reviewed membership criteria and the site’s public publication criteria.
Browse the complete catalogueResearch library
Authorship and evidence type remain explicit. Curated scholarship is never presented as Dr. Arachchige’s publication, and policy or industry material is not presented as peer-reviewed evidence.
Systematic, scoping and mixed-methods reviews with methods, status, search dates and update policies disclosed.
No public records yetPeer-reviewed outputs, dissertations, reports, investigations and external publications represented by one canonical record.
No public records yetAnnotated landmark and current studies selected for relevance, quality and their relationship to the active questions.
Reviewed selectionRegulator, government, standards-body, institutional and industry material, separated from peer-reviewed evidence.
Reviewed selectionA selective reading path through foundational and directly relevant books, monographs and chapters.
Initial reviewed selectionPublic explainers, talks, timelines and visual material with a traceable evidence basis.
Developing collectionA bounded selection of landmark or directly relevant scholarly work; it is not represented as a comprehensive bibliography.
Don Husereau, Michael Drummond, Federico Augustovski and others · BMJ
Provides the current reporting framework for transparent and decision-useful economic evaluations, including context, stakeholders and distributional considerations.
Gillian D. Sanders, Peter J. Neumann, Anirban Basu and 13 others · American Medical Association
Sets methodological and reporting recommendations for reference-case cost-effectiveness analysis used in decision-oriented health economics.
A bounded selection of authoritative policy, legal, standards or institutional material, kept distinct from peer-reviewed scholarship.
National Institute for Health and Care Excellence · National Institute for Health and Care Excellence
Provides a current operational model for prioritisation, evaluation, stakeholder participation and guidance production in a national HealthTech programme.
World Health Assembly · World Health Organization
Establishes an international policy basis for institutionalising health intervention and technology assessment in support of universal health coverage.
A selective reading path of foundational or directly relevant books and monographs.
Andrew Briggs, Karl Claxton, Mark Sculpher · Oxford University Press
Provides a foundational methods reference for probabilistic decision modelling, uncertainty and value-of-information analysis in health economic evaluation.
No public item is included until its source basis, authorship and programme relevance are verified.
Developing collection; no verified public resource is currently exposed.
Research vocabulary
Terms describe the actual programme, methods and settings. They support internal navigation and scholarly discovery without repeating hidden or irrelevant keyword lists.
Open research infrastructure
Protocols, registrations, datasets, code, evidence ledgers and citation exports appear here only after their public destination and current version have been verified.
No programme-level protocol, dataset, code package, evidence ledger or citation export has been verified as publicly accessible under the M4 asset contract.
Research agenda
Discuss this programme
Use the research-area address as the stable entry point; individual outputs and external resources retain their own authorship, publication and citation records.
Contact Dr. Arachchige